| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.092 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.041 | 0.4 |